Please login to the form below

Addressing the biggest challenges for rare disease communities

Each year, Rare Disease Day takes place worldwide on the last day in February. The main objective of Rare Disease Day is to raise awareness amongst the general public, the healthcare industry and decision-makers about rare diseases and their impact on patients' lives.


Why is Rare Disease Day so important?


Estimates vary, but the number of rare diseases the medical community has identified might exceed 7,000! A rare disease is defined as affecting fewer than 1 in 2,000 people in Europe and fewer than 200,000 Americans at any given time.

It is common that primary care physicians either do not recognise specific symptoms or don’t make the link between common symptoms and a rare disease. As a result, the patient journey to an accurate diagnosis can be long and difficult. For people living with a rare disease, their quality of life is typically greatly affected by the chronic, progressive and frequently life-threatening nature of the disease.

Rare Disease Day raises awareness and encourages the healthcare industry and decision-makers to understand the needs of those living with rare diseases. 

Treatment for rare diseases:

Whilst there is generally no cure for a rare disease, there have been huge advances in treatment options.

The goal for first generation treatments was survival, but second generation treatments are now helping patients live a more ‘normal’ life and enjoy a better quality of living.  And just last year, we saw landmark breakthroughs in advanced genetic therapies, such as viral mediated gene transfer and CAR-T therapies.

Today, thankfully, infants with rare diseases can often live much longer and grow up to enjoy the milestones of life through childhood, adolescence and adulthood.

Clearly treatment can be life-saving and life-changing. However, the lack of awareness around rare diseases, and the diagnosis challenge, still remains. And, as patients live longer, this creates whole new challenges to make sure they receive the level of care they need.

For more information about specific challenges for the rare disease communities, please read our full blog 
here.


28th February 2018

Share

Company Details

Ashfield

Contact Website

Address:
Ashfield House
Resolution Road
Ashby de la Zouch
Leicestershire
LE65 1HW
UK

Latest content on this profile

‘Delivering healthcare events with certainty and impact’
Ashfield Meetings & Events launches new website Ashfieldmeetings.com
Ashfield
The Ashfield Solution - Accelerate product uptake and maximize ROI
A pioneering multichannel optimization model powered by advanced analytics with the ability to flex resources based on real time results.
Ashfield
Patient Engagement and Experience Conference, 16-17 May
Ashfield and S3 Connected Health, Silver Sponsors at the 3rd Annual Patient Engagement and Experience Conference in Amsterdam on 16-17 May, will be speaking on how digitally enhanced Patient Support Programmes can extend the continuity and relevance of care into patients’ everyday lives.
Ashfield
Ashfield will be exhibiting at ISMPP US
On 30 April - 2 May 2018, Ashfield Healthcare Communications will be exhibiting at the 14th Annual Meeting of ISMPP at the Gaylord National Resort & Convention Center, National Harbor, MD.
Ashfield
Putting the patient first
You’ve invested millions in the development of your new drug or therapy and have successfully completed clinical trials - now you are ready to launch. Data has been collected, efficacy is understood and side effects are recorded. But an important question remains: is your target patient population prepared?
Ashfield
Ashfield joins the eyeforpharma webinar: The PSP Masterclass
Nagore Fernandez, Ashfield’s Head of Patient Services for EUCAN and Anna Baker, a Consultant in Health Psychology working closely with Ashfield, are joining an eyeforpharma panel debate: 'How Health Psychology drives winning Patient Support Programmes'. The webinar will take place Thursday 26th April at 9am New York, 2pm UK and 3pm Paris time.
Ashfield